+关注
比约克
暂无个人介绍
IP属地：中国香港
11
关注
0
粉丝
0
主题
0
勋章
主贴
热门
比约克
05-28
$三倍做空半导体ETF-Direxion Daily(SOXS)$
好伤心
比约克
04-29
$霸王茶姬(CHA)$
走了走了
比约克
07-01
$三倍做空半导体ETF-Direxion Daily(SOXS)$
哭惨了
比约克
2024-06-27
$Faraday Future(FFIE)$
哈哈哈哈
比约克
2024-07-09
说说你对这篇新闻的看法...
新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手
比约克
2024-06-28
亏麻了烦死了 打新就是坑啊
比约克
2024-06-25
$Faraday Future(FFIE)$
阿西吧 贾会计打得一手好牌呀
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3441334433685992","uuid":"3441334433685992","gmtCreate":1716170723531,"gmtModify":1719294077823,"name":"比约克","pinyin":"bykbiyueke","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","hat":"https://static.tigerbbs.com/f3e7f6253c885de8bad6403055b76aab","hatId":"award-c8da655dbb57d68ec776f214a7908b6d","hatName":"2025新年头像框","vip":1,"status":2,"fanSize":0,"headSize":11,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.11","exceedPercentage":"60.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.05","exceedPercentage":"80.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"中国香港","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":11,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":451802598048088,"gmtCreate":1751329344947,"gmtModify":1751329347192,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 哭惨了","listText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 哭惨了","text":"$三倍做空半导体ETF-Direxion Daily(SOXS)$ 哭惨了","images":[{"img":"https://static.tigerbbs.com/280146ece639c1a7e9bb99b41e2ed44d","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/451802598048088","isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":439936656359568,"gmtCreate":1748427498565,"gmtModify":1748427501226,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 好伤心","listText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 好伤心","text":"$三倍做空半导体ETF-Direxion Daily(SOXS)$ 好伤心","images":[{"img":"https://static.tigerbbs.com/558380ccf2549de1768b76d21f57b9d8","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/439936656359568","isVote":1,"tweetType":1,"viewCount":582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":429734969725808,"gmtCreate":1745937897217,"gmtModify":1745937899962,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$</a> 走了走了","listText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$</a> 走了走了","text":"$霸王茶姬(CHA)$ 走了走了","images":[{"img":"https://static.tigerbbs.com/7c2d5c48045113f9f6bed5b93ba8fdd4","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/429734969725808","isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":325633488281888,"gmtCreate":1720501990932,"gmtModify":1720502834092,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325633488281888","repostId":"1152476374","repostType":2,"repost":{"id":"1152476374","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1720487344,"share":"https://www.laohu8.com/m/news/1152476374?lang=&edition=full","pubTime":"2024-07-09 09:09","market":"hk","language":"zh","title":"新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1152476374","media":"老虎资讯综合","summary":"7月9日，$方舟健客$公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元。","content":"<html><head></head><body><p>7月9日，<a href=\"https://laohu8.com/S/06086\">方舟健客</a>公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。合共接获4371份有效申请，受理申请数目2789份，申购一手获配发H股份占所申请总数的概约百分比为40.04%。此外，国际发售股份最终数目为1666万股，相当于发售股份总数的70%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d0de53dc4dda741379d52361d12ca994\" title=\"\" tg-width=\"1059\" tg-height=\"824\"/></p><p>根据灼识咨询的资料，集团以2023年平均月活跃用户计是中国最大的线上慢性疾病管理平台。集团开展的业务专注于慢性疾病管理，以满足慢性疾病(如高血压、心血管及呼吸系统慢性疾病)患者的需求。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/17b8a0f7956202ab04a37dff5ed0a1d4\" title=\"\" tg-width=\"1311\" tg-height=\"886\"/></p><p style=\"text-align: justify;\">集团通过行业领先的H2H服务平台和线上零售药店服务平台，为患者提供全面的医疗服务，例如由集团的注册医生及内部医疗专业人员进行的后续医生咨询和电子处方服务。集团还提供线上零售药店服务，为客户提供各种药品。</p><p style=\"text-align: justify;\">截至2023年12月31日，集团的综合医疗服务及线上零售药店服务由一个拥有169名员工的慢性疾病管理服务中心及稳健的供应链提供支援。凭借集团的技术能力，集团为保健行业的主要参与者提供数字化解决方案。</p><p style=\"text-align: justify;\">截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。于2021年、2022年及2023年，集团的毛利分别为人民币2.2亿元、人民币3.81亿元及人民币4.87亿元。</p><p>筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元（基于发售价8.18港元计算）。根据招股书，公司目前拟将约67.4%的所得款项净额用于未来三年至五年的业务拓展；约16%的所得款项净额用于未来五年的研发活动；约11.6%的所得款项净额用于用于公司对线上慢性疾病管理行业价值链中的其他利益相关者的潜在投资、收购或战略联盟；约5%所得款项净额用作公司的营运资金及一般公司用途。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-07-09 09:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>7月9日，<a href=\"https://laohu8.com/S/06086\">方舟健客</a>公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。合共接获4371份有效申请，受理申请数目2789份，申购一手获配发H股份占所申请总数的概约百分比为40.04%。此外，国际发售股份最终数目为1666万股，相当于发售股份总数的70%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d0de53dc4dda741379d52361d12ca994\" title=\"\" tg-width=\"1059\" tg-height=\"824\"/></p><p>根据灼识咨询的资料，集团以2023年平均月活跃用户计是中国最大的线上慢性疾病管理平台。集团开展的业务专注于慢性疾病管理，以满足慢性疾病(如高血压、心血管及呼吸系统慢性疾病)患者的需求。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/17b8a0f7956202ab04a37dff5ed0a1d4\" title=\"\" tg-width=\"1311\" tg-height=\"886\"/></p><p style=\"text-align: justify;\">集团通过行业领先的H2H服务平台和线上零售药店服务平台，为患者提供全面的医疗服务，例如由集团的注册医生及内部医疗专业人员进行的后续医生咨询和电子处方服务。集团还提供线上零售药店服务，为客户提供各种药品。</p><p style=\"text-align: justify;\">截至2023年12月31日，集团的综合医疗服务及线上零售药店服务由一个拥有169名员工的慢性疾病管理服务中心及稳健的供应链提供支援。凭借集团的技术能力，集团为保健行业的主要参与者提供数字化解决方案。</p><p style=\"text-align: justify;\">截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。于2021年、2022年及2023年，集团的毛利分别为人民币2.2亿元、人民币3.81亿元及人民币4.87亿元。</p><p>筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元（基于发售价8.18港元计算）。根据招股书，公司目前拟将约67.4%的所得款项净额用于未来三年至五年的业务拓展；约16%的所得款项净额用于未来五年的研发活动；约11.6%的所得款项净额用于用于公司对线上慢性疾病管理行业价值链中的其他利益相关者的潜在投资、收购或战略联盟；约5%所得款项净额用作公司的营运资金及一般公司用途。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/26d35a88c8d9d9d46abd395d2bd24396","relate_stocks":{"06086":"方舟健客"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152476374","content_text":"7月9日，方舟健客公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。合共接获4371份有效申请，受理申请数目2789份，申购一手获配发H股份占所申请总数的概约百分比为40.04%。此外，国际发售股份最终数目为1666万股，相当于发售股份总数的70%。根据灼识咨询的资料，集团以2023年平均月活跃用户计是中国最大的线上慢性疾病管理平台。集团开展的业务专注于慢性疾病管理，以满足慢性疾病(如高血压、心血管及呼吸系统慢性疾病)患者的需求。集团通过行业领先的H2H服务平台和线上零售药店服务平台，为患者提供全面的医疗服务，例如由集团的注册医生及内部医疗专业人员进行的后续医生咨询和电子处方服务。集团还提供线上零售药店服务，为客户提供各种药品。截至2023年12月31日，集团的综合医疗服务及线上零售药店服务由一个拥有169名员工的慢性疾病管理服务中心及稳健的供应链提供支援。凭借集团的技术能力，集团为保健行业的主要参与者提供数字化解决方案。截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。于2021年、2022年及2023年，集团的毛利分别为人民币2.2亿元、人民币3.81亿元及人民币4.87亿元。筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元（基于发售价8.18港元计算）。根据招股书，公司目前拟将约67.4%的所得款项净额用于未来三年至五年的业务拓展；约16%的所得款项净额用于未来五年的研发活动；约11.6%的所得款项净额用于用于公司对线上慢性疾病管理行业价值链中的其他利益相关者的潜在投资、收购或战略联盟；约5%所得款项净额用作公司的营运资金及一般公司用途。","news_type":1,"symbols_score_info":{"06086":1.1}},"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":321808426541368,"gmtCreate":1719575518135,"gmtModify":1719580182172,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"亏麻了烦死了 打新就是坑啊","listText":"亏麻了烦死了 打新就是坑啊","text":"亏麻了烦死了 打新就是坑啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321808426541368","isVote":1,"tweetType":1,"viewCount":918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":321095246553336,"gmtCreate":1719422527154,"gmtModify":1719422946694,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"1\"></v-v> 哈哈哈哈","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"1\"></v-v> 哈哈哈哈","text":"$Faraday Future(FFIE)$ 哈哈哈哈","images":[{"img":"https://static.tigerbbs.com/96d931ad59778c622e4e4e7082c641b5","width":"1086","height":"1713"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321095246553336","isVote":1,"tweetType":1,"viewCount":841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":320537577513128,"gmtCreate":1719288991507,"gmtModify":1719289324887,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a> 阿西吧 贾会计打得一手好牌呀","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a> 阿西吧 贾会计打得一手好牌呀","text":"$Faraday Future(FFIE)$ 阿西吧 贾会计打得一手好牌呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/320537577513128","isVote":1,"tweetType":1,"viewCount":959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":439936656359568,"gmtCreate":1748427498565,"gmtModify":1748427501226,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 好伤心","listText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 好伤心","text":"$三倍做空半导体ETF-Direxion Daily(SOXS)$ 好伤心","images":[{"img":"https://static.tigerbbs.com/558380ccf2549de1768b76d21f57b9d8","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/439936656359568","isVote":1,"tweetType":1,"viewCount":582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":429734969725808,"gmtCreate":1745937897217,"gmtModify":1745937899962,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$</a> 走了走了","listText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$</a> 走了走了","text":"$霸王茶姬(CHA)$ 走了走了","images":[{"img":"https://static.tigerbbs.com/7c2d5c48045113f9f6bed5b93ba8fdd4","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/429734969725808","isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":451802598048088,"gmtCreate":1751329344947,"gmtModify":1751329347192,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 哭惨了","listText":"<a href=\"https://laohu8.com/S/SOXS\">$三倍做空半导体ETF-Direxion Daily(SOXS)$ </a><v-v data-views=\"1\"></v-v> 哭惨了","text":"$三倍做空半导体ETF-Direxion Daily(SOXS)$ 哭惨了","images":[{"img":"https://static.tigerbbs.com/280146ece639c1a7e9bb99b41e2ed44d","width":"1092","height":"1717"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/451802598048088","isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":321095246553336,"gmtCreate":1719422527154,"gmtModify":1719422946694,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"1\"></v-v> 哈哈哈哈","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a><v-v data-views=\"1\"></v-v> 哈哈哈哈","text":"$Faraday Future(FFIE)$ 哈哈哈哈","images":[{"img":"https://static.tigerbbs.com/96d931ad59778c622e4e4e7082c641b5","width":"1086","height":"1713"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321095246553336","isVote":1,"tweetType":1,"viewCount":841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":325633488281888,"gmtCreate":1720501990932,"gmtModify":1720502834092,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325633488281888","repostId":"1152476374","repostType":2,"repost":{"id":"1152476374","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1720487344,"share":"https://www.laohu8.com/m/news/1152476374?lang=&edition=full","pubTime":"2024-07-09 09:09","market":"hk","language":"zh","title":"新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1152476374","media":"老虎资讯综合","summary":"7月9日，$方舟健客$公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元。","content":"<html><head></head><body><p>7月9日，<a href=\"https://laohu8.com/S/06086\">方舟健客</a>公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。合共接获4371份有效申请，受理申请数目2789份，申购一手获配发H股份占所申请总数的概约百分比为40.04%。此外，国际发售股份最终数目为1666万股，相当于发售股份总数的70%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d0de53dc4dda741379d52361d12ca994\" title=\"\" tg-width=\"1059\" tg-height=\"824\"/></p><p>根据灼识咨询的资料，集团以2023年平均月活跃用户计是中国最大的线上慢性疾病管理平台。集团开展的业务专注于慢性疾病管理，以满足慢性疾病(如高血压、心血管及呼吸系统慢性疾病)患者的需求。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/17b8a0f7956202ab04a37dff5ed0a1d4\" title=\"\" tg-width=\"1311\" tg-height=\"886\"/></p><p style=\"text-align: justify;\">集团通过行业领先的H2H服务平台和线上零售药店服务平台，为患者提供全面的医疗服务，例如由集团的注册医生及内部医疗专业人员进行的后续医生咨询和电子处方服务。集团还提供线上零售药店服务，为客户提供各种药品。</p><p style=\"text-align: justify;\">截至2023年12月31日，集团的综合医疗服务及线上零售药店服务由一个拥有169名员工的慢性疾病管理服务中心及稳健的供应链提供支援。凭借集团的技术能力，集团为保健行业的主要参与者提供数字化解决方案。</p><p style=\"text-align: justify;\">截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。于2021年、2022年及2023年，集团的毛利分别为人民币2.2亿元、人民币3.81亿元及人民币4.87亿元。</p><p>筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元（基于发售价8.18港元计算）。根据招股书，公司目前拟将约67.4%的所得款项净额用于未来三年至五年的业务拓展；约16%的所得款项净额用于未来五年的研发活动；约11.6%的所得款项净额用于用于公司对线上慢性疾病管理行业价值链中的其他利益相关者的潜在投资、收购或战略联盟；约5%所得款项净额用作公司的营运资金及一般公司用途。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新股定价｜方舟健客一手中签率40.04%，认购4手稳中一手\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-07-09 09:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>7月9日，<a href=\"https://laohu8.com/S/06086\">方舟健客</a>公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。合共接获4371份有效申请，受理申请数目2789份，申购一手获配发H股份占所申请总数的概约百分比为40.04%。此外，国际发售股份最终数目为1666万股，相当于发售股份总数的70%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d0de53dc4dda741379d52361d12ca994\" title=\"\" tg-width=\"1059\" tg-height=\"824\"/></p><p>根据灼识咨询的资料，集团以2023年平均月活跃用户计是中国最大的线上慢性疾病管理平台。集团开展的业务专注于慢性疾病管理，以满足慢性疾病(如高血压、心血管及呼吸系统慢性疾病)患者的需求。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/17b8a0f7956202ab04a37dff5ed0a1d4\" title=\"\" tg-width=\"1311\" tg-height=\"886\"/></p><p style=\"text-align: justify;\">集团通过行业领先的H2H服务平台和线上零售药店服务平台，为患者提供全面的医疗服务，例如由集团的注册医生及内部医疗专业人员进行的后续医生咨询和电子处方服务。集团还提供线上零售药店服务，为客户提供各种药品。</p><p style=\"text-align: justify;\">截至2023年12月31日，集团的综合医疗服务及线上零售药店服务由一个拥有169名员工的慢性疾病管理服务中心及稳健的供应链提供支援。凭借集团的技术能力，集团为保健行业的主要参与者提供数字化解决方案。</p><p style=\"text-align: justify;\">截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。于2021年、2022年及2023年，集团的毛利分别为人民币2.2亿元、人民币3.81亿元及人民币4.87亿元。</p><p>筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元（基于发售价8.18港元计算）。根据招股书，公司目前拟将约67.4%的所得款项净额用于未来三年至五年的业务拓展；约16%的所得款项净额用于未来五年的研发活动；约11.6%的所得款项净额用于用于公司对线上慢性疾病管理行业价值链中的其他利益相关者的潜在投资、收购或战略联盟；约5%所得款项净额用作公司的营运资金及一般公司用途。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/26d35a88c8d9d9d46abd395d2bd24396","relate_stocks":{"06086":"方舟健客"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152476374","content_text":"7月9日，方舟健客公布配发结果，每股定价8.18港元，共发行2380万股股份，每手500股，预期7月9日上市。公开发售阶段方舟健客获16.63倍认购，公开发售的发售股份最终数目为714万股股份，占发售股份总数的约30%。合共接获4371份有效申请，受理申请数目2789份，申购一手获配发H股份占所申请总数的概约百分比为40.04%。此外，国际发售股份最终数目为1666万股，相当于发售股份总数的70%。根据灼识咨询的资料，集团以2023年平均月活跃用户计是中国最大的线上慢性疾病管理平台。集团开展的业务专注于慢性疾病管理，以满足慢性疾病(如高血压、心血管及呼吸系统慢性疾病)患者的需求。集团通过行业领先的H2H服务平台和线上零售药店服务平台，为患者提供全面的医疗服务，例如由集团的注册医生及内部医疗专业人员进行的后续医生咨询和电子处方服务。集团还提供线上零售药店服务，为客户提供各种药品。截至2023年12月31日，集团的综合医疗服务及线上零售药店服务由一个拥有169名员工的慢性疾病管理服务中心及稳健的供应链提供支援。凭借集团的技术能力，集团为保健行业的主要参与者提供数字化解决方案。截至2021年、2022年及2023年12月31日止年度，集团的收入分别为人民币17.59亿元、人民币22.04亿元及人民币24.34亿元。于2021年、2022年及2023年，集团的毛利分别为人民币2.2亿元、人民币3.81亿元及人民币4.87亿元。筹资用途方面，方舟健客预计全球发售所得款项净额约6709万港元（基于发售价8.18港元计算）。根据招股书，公司目前拟将约67.4%的所得款项净额用于未来三年至五年的业务拓展；约16%的所得款项净额用于未来五年的研发活动；约11.6%的所得款项净额用于用于公司对线上慢性疾病管理行业价值链中的其他利益相关者的潜在投资、收购或战略联盟；约5%所得款项净额用作公司的营运资金及一般公司用途。","news_type":1,"symbols_score_info":{"06086":1.1}},"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":321808426541368,"gmtCreate":1719575518135,"gmtModify":1719580182172,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"亏麻了烦死了 打新就是坑啊","listText":"亏麻了烦死了 打新就是坑啊","text":"亏麻了烦死了 打新就是坑啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321808426541368","isVote":1,"tweetType":1,"viewCount":918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":320537577513128,"gmtCreate":1719288991507,"gmtModify":1719289324887,"author":{"id":"3441334433685992","authorId":"3441334433685992","name":"比约克","avatar":"https://static.tigerbbs.com/826051ff7dcb408e8a514777c5146878","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3441334433685992","authorIdStr":"3441334433685992"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a> 阿西吧 贾会计打得一手好牌呀","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$ </a> 阿西吧 贾会计打得一手好牌呀","text":"$Faraday Future(FFIE)$ 阿西吧 贾会计打得一手好牌呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/320537577513128","isVote":1,"tweetType":1,"viewCount":959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
